As the winter season approaches, Health Canada has approved several vaccines and therapies to protect infants across Canada against RSV (respiratory syncytial virus) – a viral infection that affects the respiratory tract. However, access to these crucial protection methods varies across the country.
In some provinces, healthcare facilities have adapted quickly to provide widespread access to vaccines and therapies for RSV protection. These proactive measures ensure that as many infants as possible are able to receive the necessary care to prevent the spread of the virus.
On the other hand, in certain regions, access to RSV protection for infants is limited due to logistical challenges or shortages of vaccines. This disparity in access highlights the need for consistent and equitable distribution of healthcare resources across all provinces in Canada.
It is crucial for healthcare providers and policymakers to work together to address these gaps in access to RSV protection for infants. By ensuring that all Canadians have equal access to these life-saving vaccines and therapies, we can better protect our most vulnerable population from the health risks associated with RSV.
Watch the video by Global News
Video “Access to infant RSV protection differs across Canada” was uploaded on 09/22/2024 to Youtube Channel Global News